|
|||||
|
|
EORTC new drug development office coordinating and monitoring programme for phase I and II trials with new anticancer agents |
|
| Affiliation: | 1. EORTC New Drug Development Office (NDDO), Amsterdam, The Netherlands;2. EORTC Protocol Review Committee (PRC), Amsterdam, The Netherlands;3. EORTC Data Center, Amsterdam, The Netherlands;4. EORTC Quality Control Committee (QCC), Amsterdam, The Netherlands;5. EORTC Early Clinical Trials Group (ECTG) and New Drug Development Coordinating Committee (NDDCC) Amsterdam, The Netherlands |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |